Clinical Trials Logo

Essential Hypertension clinical trials

View clinical trials related to Essential Hypertension.

Filter by:

NCT ID: NCT00328965 Completed - Clinical trials for Diabetes Mellitus, Type 2

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Start date: November 2004
Phase: Phase 4
Study type: Interventional

This study was designed to evaluate the anti-hypertensive efficacy of lacidipine in hypertensives with Type 2 diabetes and effectiveness on endothelial cell function in Korean population.

NCT ID: NCT00311155 Completed - Clinical trials for Essential Hypertension

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

OLMETREAT
Start date: March 2006
Phase: Phase 4
Study type: Interventional

This study is to assess the safety and efficacy of an add-on treatment algorithm with olmesartan, hydrochlorothiazide and amlodipine in patients with mild to moderate hypertension.

NCT ID: NCT00298129 Completed - Diabetes Mellitus Clinical Trials

Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease

Start date: February 2004
Phase: N/A
Study type: Observational

Many patients with chronic renal disease show a loss of the nocturnal decline of blood pressure (non-dipper). However, the mechanism is not yet fully understood. We evaluate 24-hour blood pressure in patients with chronic renal disease using an ambulatory blood pressure monitoring device (A & D TM2425). We also analyze the power spectrum of heart rate variability as an index of autonomic cardiovascular modulation using the same device.

NCT ID: NCT00295555 Completed - Diabetes Mellitus Clinical Trials

Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy

Start date: January 2004
Phase: Phase 4
Study type: Interventional

Few studies have reported the effect of alpha1-adrenergic antagonists on 24-h blood pressure and regulation of sympathetic nervous activity in hypertensive patients with diabetic nephropathy. Using ambulatory blood pressure monitoring devices equipped with spectral analysis of heart rate variability, we assess the effects of doxazosin on blood pressure in diabetic nephropathy patients and compare the results with those in patients with essential hypertension, patients with diabetes mellitus and patients with chronic nephropathy.

NCT ID: NCT00288184 Completed - Clinical trials for Essential Hypertension

Uric Acid in Essential Hypertension in Children

Start date: September 2004
Phase: Phase 2
Study type: Interventional

The study is a randomized, double-blinded, placebo controlled, crossover trial of allopurinol for the treatment of children with newly diagnosed essential hypertension.

NCT ID: NCT00286884 Completed - Healthy Clinical Trials

Heart Rate Variability in White Coat Hypertension and Essential Hypertension

Start date: n/a
Phase: N/A
Study type: Observational

The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.

NCT ID: NCT00254475 Completed - Clinical trials for Hypercholesterolemia

A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to provide data on the dose response of simvastatin in lowering LDL-C when it is co-administered with valsartan in patients with both essential hypertension and hypercholesterolemia. The primary objective of the study will be to show that the combination of valsartan 160mg/simvastatin 40mg has superior efficacy compared to the combination of valsartan 160mg/simvastatin 20mg in percentage change from baseline in LDL-C.

NCT ID: NCT00220233 Completed - Clinical trials for Essential Hypertension

Olmesartan as an add-on to Amlodipine in Hypertension

Start date: April 2005
Phase: Phase 3
Study type: Interventional

This study is to test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with amlodipine alone

NCT ID: NCT00220220 Completed - Clinical trials for Essential Hypertension

Amlodipine as add-on to Olmesartan in Hypertension

Start date: April 2005
Phase: Phase 3
Study type: Interventional

Test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with olmesartan alone.

NCT ID: NCT00185185 Completed - Clinical trials for Essential Hypertension

Olmesartan Medoxomil in Atherosclerosis

Start date: November 2001
Phase: Phase 3
Study type: Interventional

This is a study in hypertensive patients with atherosclerosis and increased cardiovascular risk. The efficacy of olmesartan medoxomil on atherosclerosis is measured.